Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?

Affiliations

¹ Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. Electronic address: andreas.charidimou.09@ucl.ac.uk.
² Lysholm Department of Neuroradiology, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK; Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK.

Comment

Andreas Charidimou et al. Lancet Neurol. 2014 Jun.

. 2014 Jun;13(6):538-40.

doi: 10.1016/S1474-4422(14)70096-1.

¹ Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. Electronic address: andreas.charidimou.09@ucl.ac.uk.
² Lysholm Department of Neuroradiology, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK; Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK.

No abstract available

Comment in

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply.
Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ. Greenberg SM, et al. Lancet Neurol. 2014 Jun;13(6):540. doi: 10.1016/S1474-4422(14)70097-3. Lancet Neurol. 2014. PMID: 24849857 Free PMC article. No abstract available.

Outcome markers for clinical trials in cerebral amyloid angiopathy.
Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ. Greenberg SM, et al. Lancet Neurol. 2014 Apr;13(4):419-28. doi: 10.1016/S1474-4422(14)70003-1. Epub 2014 Feb 27. Lancet Neurol. 2014. PMID: 24581702 Free PMC article. Review.